Innovating Works

BIOMATLANTE

Desconocido
ORTHO-ALLO-UNION: ORTHOpaedic treatment with ALLOgenic combined ATMP in long bone fracture delayed UNION and non union... BIOMATLANTE participó en un HORIZON EUROPE: HORIZON-HLTH-2023-TOOL-05 Bone fracture with delay or failure to heal is a condition with huge health impact. Although only a small proportion of long bone fractures...
2023-11-28 - 2028-11-30 | Financiado
ORTHOUNION: ORTHOpedic randomized clinical trial with expanded bone marrow MSC and bioceramics versus autograft... BIOMATLANTE participó en un H2020: H2020-SC1-2016-2017 Current orthopaedic treatments permit spontaneous bone regeneration to unite and heal 90% bone injuries. Non-union associates pain and disab...
2016-12-12 - 2022-06-30 | Financiado
GAMBA: Gene Activated Matrices for Bone and Cartilage Regeneration in Arthritis BIOMATLANTE participó en un FP7: This consortium develops a novel gene-activated matrix platform for bone and cartilage repair with a focus on osteoarthritis-related tissue...
Financiado
REBORNE: Regenerating Bone defects using New biomedical Engineering approaches BIOMATLANTE participó en un FP7: Bone is among the most frequently transplanted tissue with about 1 million procedures annually in Europe. The worldwide market of bone repla...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.